Cited by 684Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchEpilepsy research and treatment

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Epilepsy and Cognitive Impairments in Alzheimer Disease

Open access

Palop, Jorge J.·2009·Archives of Neurology

DOI 10.1001/archneurol.2009.15PMC PMC2812914

Open this paper in CoChat — free account

Abstract

Alzheimer disease (AD) is associated with cognitive decline and increased incidence of seizures. Seizure activity in AD has been widely interpreted as a secondary process resulting from advanced stages of neurodegeneration, perhaps in combination with other age-related factors. However, recent findings in animal models of AD have challenged this notion, raising the possibility that aberrant excitatory neuronal activity represents a primary upstream mechanism that may contribute to cognitive deficits in these models. The following observations suggest that such activity may play a similar role in humans with AD: (1) patients with sporadic AD have an increased incidence of seizures that appears to be independent of disease stage and highest in cases with early onset; (2) seizures are part of the natural history of many pedigrees with autosomal dominant early-onset AD, including those with mutations in presenilin-1, presenilin-2, or the amyloid precursor protein, or with duplications of wild-type amyloid precursor protein; (3) inheritance of the major known genetic risk factor for AD, apolipoprotein E4, is associated with subclinical epileptiform activity in carriers without dementia; and (4) some cases of episodic amnestic wandering and disorientation in AD are associated with epileptiform activity and can be prevented with antiepileptic drugs. Here we review recent experimental data demonstrating that high levels of beta-amyloid in the brain can cause epileptiform activity and cognitive deficits in transgenic mouse models of AD. We conclude that beta-amyloid peptides may contribute to cognitive decline in AD by eliciting similar aberrant neuronal activity in humans and discuss potential clinical and therapeutic implications of this hypothesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/archneurol.2009.15

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Self-citation
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of alzheimer’s disease.
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
Self-citation
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V. P., Hyman, B. T., et al. (1999) · Nature Neuroscience · doi:10.1038/6374 · Cited by 946
Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912

Show all 47 references

Sorted by citations

Items 301–400 of 675

Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience
Aboud, O., Mrak, R. E., Boop, F. A., & Griffin, S. T. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-35 · Cited by 34
Early hippocampal hyperexcitability in PS2APP mice: role of mutant PS2 and APP
Fontana, R., Agostini, M., Murana, E., Mahmud, M., Scremin, E., Rubega, M., Sparacino, G., Vassanelli, S., & Fasolato, C. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.10.027 · Cited by 35
Epileptic seizures in autosomal dominant forms of Alzheimer’s disease
Cortini, F., Cantoni, C., & Villa, C. (2018) · Seizure · doi:10.1016/j.seizure.2018.07.015 · Cited by 34
Ovarian Cycle Stages Modulate Alzheimer-Related Cognitive and Brain Network Alterations in Female Mice
Broestl, L., Worden, K., Moreno, A. J., Davis, E. J., Wang, D., Garay, B. I., Singh, T., Verret, L., Palop, J. J., & Dubal, D. B. (2018) · eNeuro · doi:10.1523/eneuro.0132-17.2018 · Cited by 35
Self-citation
Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?
Rodríguez-Jiménez, F. J., Ureña‐Peralta, J. R., Jendelová, P., & Erceg, S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.006 · Cited by 33
Restoring neuronal chloride extrusion reverses cognitive decline linked to Alzheimer’s disease mutations
Keramidis, I., McAllister, B. B., Bourbonnais, J., Wang, F., Isabel, D., Rezaei, E., Sansonetti, R., Degagne, P., Hamel, J. P., Nazari, M., et al. (2023) · Brain · doi:10.1093/brain/awad250 · Cited by 37
Abeta(1-42) Enhances Neuronal Excitability in the CA1 via NR2B Subunit-Containing NMDA Receptors
Varga, E., Juhász, G., Bozsó, Z., Penke, B., Fülöp, L., & Szegedi, V. (2014) · Neural Plasticity · doi:10.1155/2014/584314 · Cited by 35
Opposite Effects of Low and High Doses of Aβ42 on Electrical Network and Neuronal Excitability in the Rat Prefrontal Cortex
Wang, Y., Zhang, G., Zhou, H., Barakat, A., & Querfurth, H. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008366 · Cited by 34
Amyloid Beta A4 Precursor Protein-binding Family B Member 1 (FE65) Interactomics Revealed Synaptic Vesicle Glycoprotein 2A (SV2A) and Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2 (SERCA2) as New Binding Proteins in the Human Brain
Nensa, F. M., Neumann, M. H., Schrötter, A., Przyborski, A., Mastalski, T., Susdalzew, S., Looβe, C., Helling, S., Magraoui, F. E., Erdmann, R., et al. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.029280 · Cited by 33
Synaptic Pathology of Down Syndrome
Garner, C. C., & Wetmore, D. Z. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_20 · Cited by 33
BACE1-dependent cleavage of GABAA receptor contributes to neural hyperexcitability and disease progression in Alzheimer’s disease
Bi, D., Bao, H., Yang, X., Wu, Z., Yang, X., Xu, G., Liu, X., Wan, Z., Liu, J., He, J., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.01.030 · Cited by 32
Alzheimer's and Seizures: Interleukin-18, Indoleamine 2,3-Dioxygenase and Quinolinic Acid
Anderson, G., & Ojala, J. O. (2010) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s4603 · Cited by 32
Envisioning the neuroprotective effect of Metformin in experimental epilepsy: A portrait of molecular crosstalk
Nandini, H. S., Paudel, Y. N., & Krishna, K. L. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116686 · Cited by 32
Ten year cumulative incidence of dementia after late onset epilepsy of unknown etiology
Keret, O., Brauner, R., Benninger, F., & Glik, A. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.01.030 · Cited by 32
Gastrodin Suppresses the Amyloidβ-Induced Increase of Spontaneous Discharge in the Entorhinal Cortex of Rats
Chen, P.-Z., Jiang, H., Wen, B., Ren, S., Chen, Y., Ji, W.-G., Hu, B., Zhang, J., Xu, F., & Zhu, Z.-R. (2014) · Neural Plasticity · doi:10.1155/2014/320937 · Cited by 32
Abnormal Population Responses in the Somatosensory Cortex of Alzheimer’s Disease Model Mice
Maatuf, Y., Stern, E. A., & Slovin, H. (2016) · Scientific Reports · doi:10.1038/srep24560 · Cited by 34
Targeting Insulin for Alzheimer’s Disease: Mechanisms, Status and Potential Directions
Lee, J. H., Jahrling, J. B., Denner, L. A., & Dineley, K. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179923 · Cited by 36
Dampened Slow Oscillation Connectivity Anticipates Amyloid Deposition in the PS2APP Mouse Model of Alzheimer’s Disease
Leparulo, A., Mahmud, M., Scremin, E., Pozzan, T., Vassanelli, S., & Fasolato, C. (2019) · Cells · doi:10.3390/cells9010054 · Cited by 31
Impaired pattern separation in Tg2576 mice is associated with hyperexcitable dentate gyrus caused by Kv4.1 downregulation
Kim, K.-R., Kim, Y., Jeong, H., Kang, J.-S., Lee, S. H., Kim, Y., Lee, S., & Ho, W. (2021) · Molecular Brain · doi:10.1186/s13041-021-00774-x · Cited by 33
Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease
Gutierrez, B. A., & Limón, A. (2022) · Biomedicines · doi:10.3390/biomedicines10071743 · Cited by 32
Deep brain stimulation of thalamic nucleus reuniens promotes neuronal and cognitive resilience in an Alzheimer’s disease mouse model
Shoob, S., Buchbinder, N., Shinikamin, O., Gold, O., Baeloha, H., Langberg, T., Zarhin, D., Shapira, I., Braun, G., Habib, N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42721-5 · Cited by 33
Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus
Chali, F., Djelti, F., Eugène, E., Valderrama, M., Marquer, C., Aubourg, P. R., Duyckaerts, C. J., Miles, R., Cartier, N., & Navarro, V. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12911 · Cited by 33
Hippocampal 5-HT1A receptor expression changes in prodromal stages of Alzheimer's disease: Beneficial or deleterious?
Verdurand, M., & Zimmer, L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.021 · Cited by 35
Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling
de Leeuw, S., & Tackenberg, C. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0161-0 · Cited by 31
An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): A double-blind, placebo-controlled, randomised crossover proof of concept study
Sen, A., Akinola, M., Tai, X. Y., Symmonds, M., Davis Jones, G., Mura, S., Galloway, J., Hallam, A., Chan, J. Y. C., Koychev, I., et al. (2021) · Trials · doi:10.1186/s13063-021-05404-4 · Cited by 30
Somatostatin and the pathophysiology of Alzheimer’s disease
Almeida, V. N. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102270 · Cited by 31
Screening of acetylcholinesterase inhibitors and characterizing of phytochemical constituents from Dichocarpum auriculatum (Franch.) W.T. Wang & P. K. Hsiao through UPLC-MS combined with an acetylcholinesterase inhibition assay in vitro
Li, P. S., Liu, S., Liu, Q., Shen, J., Yang, R., Jiang, B., He, C., & Xiao, P. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112185 · Cited by 30
Bioinformatics Methodologies to Identify Interactions Between Type 2 Diabetes and Neurological Comorbidities
Rahman, M. H., Peng, S., Hu, X., Chen, C., Uddin, S., Quinn, J. M. W., & Moni, M. A. (2019) · IEEE Access · doi:10.1109/access.2019.2960037 · Cited by 30
Disrupted neural correlates of anesthesia and sleep reveal early circuit dysfunctions in Alzheimer models
Zarhin, D., Atsmon, R., Ruggiero, A., Baeloha, H., Shoob, S., Scharf, O., Heim, L. R., Buchbinder, N., Shinikamin, O., Shapira, I., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110268 · Cited by 32
The Brain, Seizures and Epilepsy Throughout Life: Understanding a Moving Target
Baram, T. Z. (2012) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-12.4s.7 · Cited by 31
Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse Model
Tanghe, A., Termont, A., Merchiers, P., Schilling, S., Demuth, H., Scrocchi, L. A., LEUVEN, F. V., Griffioen, G., & Dooren, T. V. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/417314 · Cited by 31
A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity
Rush, T., Roth, J. R., Thompson, S. J., Aldaher, A. R., Cochran, J. N., & Roberson, E. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104668 · Cited by 30
Levetiracetam Treatment Normalizes Levels of Presynaptic Endocytosis Machinery and Restores Nonamyloidogenic APP Processing in App Knock-in Mice
Rao, N. R., & Savas, J. N. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00180 · Cited by 29
Diagnosis of Alzheimer’s disease: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
Schilling, L. P., Balthazar, M. L. F., Radanovic, M., Forlenza, O. V., Silagi, M. L., Smid, J., Barbosa, B. J. A. P., Frota, N. A. F., de Souza, L. C., Vale, F. A. C., et al. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-s102en · Cited by 29
Age-dependent effect of Alzheimer’s risk variant of CLU on EEG alpha rhythm in non-demented adults
Пономарева, Н. В., Андреева, Т. В., Protasova, M., Shagam, L., Malina, D. D., Goltsov, A., Fokin, V. F., Алексеевич, М. А., & Rogaev, E. I. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00086 · Cited by 29
From Molecular Circuit Dysfunction to Disease
Dulla, C. G., Coulter, D. A., & Žiburkus, J. (2015) · The Neuroscientist · doi:10.1177/1073858415585108 · Cited by 29
Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease
Love, M. N., Clark, D. G., Cochran, J. N., Beste, K. A. D., Geldmacher, D., Benzinger, T. L. S., Gordon, B. A., Morris, J. C., Bateman, R. J., & Roberson, E. D. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.09.020 · Cited by 28
Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
Marshall, C. A., McBride, J. D., Changolkar, L. N., Riddle, D. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01331-w · Cited by 28
Alzheimer’s Disease and Neuronal Network Activity
Gleichmann, M., & Mattson, M. P. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8100-3 · Cited by 29
Epilepsy in patients with Alzheimer's disease: A systematic review
Miranda, D. D. C., & Brucki, S. M. D. (2014) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642014dn81000010 · Cited by 28
On the relationships between epilepsy, sleep, and Alzheimer’s disease: A narrative review
Hanke, J.-M., Schindler, K. A., & Seiler, A. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108609 · Cited by 28
Aß Pathology and Neuron–Glia Interactions: A Synaptocentric View
Huffels, C. F. M., Middeldorp, J., & Hol, E. M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03699-6 · Cited by 29
Alzheimer's secretases regulate voltage-gated sodium channels
Kovacs, D. M., Gersbacher, M. T., & Kim, D. Y. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.08.048 · Cited by 27
MicroRNA-9 induces defective trafficking of Nav1.1 and Nav1.2 by targeting Navβ2 protein coding region in rat with chronic brain hypoperfusion
Sun, L., Yan, M., Hu, X., Peng, L.-W., Che, H., Bao, Y., Guo, F., Liu, T., Chen, X., Zhang, R., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0032-9 · Cited by 27
Polo-like kinase 2 phosphorylation of amyloid precursor protein regulates activity-dependent amyloidogenic processing
Lee, Y., Lee, J. S., Lee, K. J., Turner, R. S., Hoe, H.-S., & Pak, D. T. S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.027 · Cited by 27
Novel interaction between Alzheimer’s disease-related protein presenilin 1 and glutamate transporter 1
Zoltowska, K. M., Maesako, M., Meier, J. C., & Berezovska, O. (2018) · Scientific Reports · doi:10.1038/s41598-018-26888-2 · Cited by 27
Inhibition of Polo-like kinase 2 ameliorates pathogenesis in Alzheimer’s disease model mice
Lee, J. S., Lee, Y., André, E. A., Lee, K. J., Nguyen, T., Feng, Y., Jia, N., Harris, B. T., Burns, M. P., & Pak, D. T. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219691 · Cited by 30
Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer’s Disease
Müller, L., Kirschstein, T., Köhling, R., Kuhla, A., & Teipel, S. J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201540 · Cited by 27
Cerebal overinhibition could be the basis for the high prevalence of epilepsy in persons with Down syndrome
Araújo, B. H. S., Torres, L. B., & Guilhoto, L. M. D. F. F. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.10.004 · Cited by 27
Loss of presenilin 2 age-dependently alters susceptibility to acute seizures and kindling acquisition
Beckman, M., Knox, K. M., Koneval, Z., Smith, C., Jayadev, S., & Barker‐Haliski, M. L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104719 · Cited by 26
Recent Insights on Glutamatergic Dysfunction in Alzheimer’s Disease and Therapeutic Implications
Pinky, P. D., Pfitzer, J. C., Senfeld, J. I., Hong, H., Bhattacharya, S., Suppiramaniam, V. D., Qureshi, I., & Reed, M. N. (2022) · The Neuroscientist · doi:10.1177/10738584211069897 · Cited by 27
Aberrant protein S-nitrosylation contributes to hyperexcitability-induced synaptic damage in Alzheimer’s disease: Mechanistic insights and potential therapies
Ghatak, S., Nakamura, T., & Lipton, S. A. (2023) · Frontiers in Neural Circuits · doi:10.3389/fncir.2023.1099467 · Cited by 26
Interictal spikes in Alzheimer's disease: Preclinical evidence for dominance of the dentate gyrus and cholinergic control by the medial septum
Lisgaras, C. P., & Scharfman, H. E. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106294 · Cited by 26
Use of Antiepileptic Drugs Among Community-Dwelling Persons with Alzheimer's Disease in Finland
Bell, J. S., Lönnroos, E., Koivisto, A. M., Lavikainen, P., Laitinen, M.-L., Soininen, H. S., & Hartikainen, S. A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110200 · Cited by 26
Can the syndrome of transient epileptic amnesia be the first feature of Alzheimer's disease?
Cretin, B., Philippi, N., Sellal, F., Bitonto, L. D., Martin‐Hunyadi, C., & Blanc, F. (2014) · Seizure · doi:10.1016/j.seizure.2014.07.008 · Cited by 26
Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome
Das, D., Phillips, C., Hsieh, W., Sumanth, K., Dang, V., & Salehi, A. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.05.004 · Cited by 27
3D bioengineered neural tissue generated from patient-derived iPSCs mimics time-dependent phenotypes and transcriptional features of Alzheimer’s disease
Lomoio, S., Pandey, R. S., Rouleau, N., Menicacci, B., Kim, W., Cantley, W. L., Haydon, P. G., Bennett, D. A., Young-Pearse, T. L., Carter, G. W., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02147-3 · Cited by 25
Auditory gamma-band entrainment enhances default mode network connectivity in dementia patients
Lahijanian, M., Aghajan, H. K., & Vahabi, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-63727-z · Cited by 26
Extracellular vesicles drive tau spreading in Alzheimer's disease
Ruan, Z. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.317975 · Cited by 25
Poststroke Seizures and the Risk of Dementia Among Young Stroke Survivors
Lekoubou, A., Ba, D. M., Nguyen, C., Liu, G., LESLIE, D. L., Bonilha, L., & Vernon, C. M. (2022) · Neurology · doi:10.1212/wnl.0000000000200736 · Cited by 25
Mechanisms and Functions of Activity-Regulated Cytoskeleton-Associated Protein in Synaptic Plasticity
Chen, Y., Wang, X., Xiao, B., Luo, Z., & Long, H. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03442-4 · Cited by 26
Epileptic Amnesic Syndrome revealing Alzheimer's disease
Cretin, B., Blanc, F., Gaultier, C., & Sellal, F. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.08.002 · Cited by 25
Head trauma and epilepsy
Pitkänen, A., & Bolkvadze, T. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02817.x · Cited by 25
Pyroglutamate-Modified Amyloid-β(3–42) Shows α-Helical Intermediates before Amyloid Formation
Dammers, C., Reiß, K., Gremer, L., Lecher, J., Ziehm, T., Stoldt, M., Schwarten, M., & Willbold, D. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.03.007 · Cited by 25
Slow and Fast Neocortical Oscillations in the Senescence-Accelerated Mouse Model SAMP8
Castano-Prat, P., Pérez‐Zabalza, M., Perez-Mendez, L., Escorihuela, R. M., & Sanchez-Vives, M. V. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00141 · Cited by 26
Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer’s disease
Cretin, B. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1496237 · Cited by 25
A Comparative Study of Machine Learning and Deep Learning Models for Automatic Parkinson’s Disease Detection from Electroencephalogram Signals
Bera, S., Geem, Z. W., Cho, Y. I., & Singh, P. K. (2025) · Diagnostics · doi:10.3390/diagnostics15060773 · Cited by 24
Epileptic Prodromal Alzheimer’s Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition
Hautecloque, G., Sellal, F., Bousiges, O., Phillipi, N., Blanc, F., & Cretin, B. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221197 · Cited by 24
Clinical and Genetic Aspects of Epilepsy
Heron, S., & Mulley, J. (2011) · InTech eBooks · doi:10.5772/1138 · Cited by 24
Amyloid precursor protein modulates Nav1.6 sodium channel currents through a Go-coupled JNK pathway
Li, S., Wang, X., Ma, Q., Yang, W.-L., Zhang, X., Dawe, G. S., & Xiao, Z. (2016) · Scientific Reports · doi:10.1038/srep39320 · Cited by 24
Early changes in synaptic and intrinsic properties of dentate gyrus granule cells in a mouse model of Alzheimer's disease neuropathology and atypical effects of the cholinergic antagonist atropine
Alcantara‐Gonzalez, D., Chartampila, E., Criscuolo, C., & Scharfman, H. E. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105274 · Cited by 25
Endogenous adenosine induces NMDA receptor-independent persistent epileptiform discharges in dorsal and ventral hippocampus via activation of A2 receptors
Moschovos, C., Kostopoulos, G., & Papatheodoropoulos, C. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.02.012 · Cited by 24
Sleep, neuronal hyperexcitability, inflammation and neurodegeneration: Does early chronic short sleep trigger and is it the key to overcoming Alzheimer’s disease?
Ahnaou, A., & Drinkenburg, W. H. I. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.039 · Cited by 24
Electrophysiological Biomarkers of Epileptogenicity in Alzheimer’s Disease
Yu, T., Liu, X., Wu, J., & Wang, Q. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.747077 · Cited by 23
Epilepsy in Early Onset Alzheimer’s Disease
Haoudy, S., Jonveaux, T., Puisieux, S., Epstein, J., Hopes, L., Maillard, L. G., Aron, O., & Tyvaert, L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210681 · Cited by 23
Deep Tissue Penetration of Bottle-Brush Polymers via Cell Capture Evasion and Fast Diffusion
Rabanel, J., Mirbagheri, M., Olszewski, M., Xie, G., Goas, M. L., Latreille, P., Counil, H., Hervé, V., Silva, R. O., Zaouter, C., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c10554 · Cited by 23
First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models
Kelly, J., Boyle, N. T., Cole, N., Slator, G. R., Colivicchi, M. A., Stefanini, C., Gobbo, O. L., Scalabrino, G., Ryan, S. M., Elamin, M., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.024 · Cited by 23
Reduction of epileptiform activity by valproic acid in a mouse model of Alzheimer's disease is not long-lasting after treatment discontinuation
Ziyatdinova, S., Viswanathan, J., Hiltunen, M. O., Tanila, H., & Pitkänen, A. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.02.005 · Cited by 23
Risk of severe and repetitive traumatic brain injury in persons with epilepsy: A population-based case–control study
Wilson, D. A., & Selassie, A. W. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.12.035 · Cited by 23
Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer’s-Like Pathological Features in Mice
Ghosal, K., Fan, Q., Dawson, H. N., & Pimplikar, S. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159435 · Cited by 24
Novel Quantitative Analyses of Spontaneous Synaptic Events in Cortical Pyramidal Cells Reveal Subtle Parvalbumin-Expressing Interneuron Dysfunction in a Knock-In Mouse Model of Alzheimer’s Disease
Chen, L., Saito, T., Saido, T. C., & Módy, I. (2018) · eNeuro · doi:10.1523/eneuro.0059-18.2018 · Cited by 27
Single amyloid‐beta injection exacerbates 4‐aminopyridine‐induced seizures and changes synaptic coupling in the hippocampus
Alcantara‐Gonzalez, D., Villasana‐Salazar, B., & Peña‐Ortega, F. (2019) · Hippocampus · doi:10.1002/hipo.23129 · Cited by 23
Empirical Mode Decomposition for Deep Learning-Based Epileptic Seizure Detection in Few-Shot Scenario
Pan, Y., Dong, F., Yao, W., Meng, X., & Xu, Y. (2024) · IEEE Access · doi:10.1109/access.2024.3415716 · Cited by 22
Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-β Variants and Structural Analysis by Solution NMR Spectroscopy
Dammers, C., Gremer, L., Neudecker, P., Demuth, H., Schwarten, M., & Willbold, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139710 · Cited by 22
Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer’s disease pathology
Jacob, S., Davies, G., Bock, M. D., Hermans, B., Wintmolders, C., Bottelbergs, A., Borgers, M., Theunis, C., Broeck, B. V., Manyakov, N. V., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51928-w · Cited by 22
Cell competition from development to neurodegeneration
RODRIGUES, M. C., Couceiro, J., & Moreno, E. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048926 · Cited by 22
Neurotransmitter release progressively desynchronizes in induced human neurons during synapse maturation and aging
Uzay, B., Houcek, A., Ma, Z., Konradi, C. L., Monteggia, L. M., & Kavalali, E. T. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112042 · Cited by 22
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
Bosco, F., Guarnieri, L., Rania, V., Palma, E., Citraro, R., Corasaniti, M. T., Leo, A., & Sarro, G. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612639 · Cited by 22
Single‐Cell Patch‐Clamp/Proteomics of Human Alzheimer's Disease iPSC‐Derived Excitatory Neurons Versus Isogenic Wild‐Type Controls Suggests Novel Causation and Therapeutic Targets
Ghatak, S., Diedrich, J. K., Talantova, M. V., Bhadra, N., Scott, H. R., Sharma, M., Albertolle, M. E., Schork, N. J., Yates, J. R., & Lipton, S. A. (2024) · Advanced Science · doi:10.1002/advs.202400545 · Cited by 22
The Brain’s Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer’s Disease
Pandya, S., Initiative, A. D. N., Kuceyeski, A. F., & Raj, A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160090 · Cited by 24
The overlap between epilepsy and Alzheimer’s disease and the consequences for treatment
Powell, G. A., Ziso, B., & Larner, A. J. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1629289 · Cited by 22
Bace1 Deletion in the Adult Reverses Epileptiform Activity and Sleep–wake Disturbances in AD Mice
Yao, A. Y., Halloran, P. J., Ge, Y., Singh, N., Zhou, J., Galske, J., He, W., Yan, R., & Hu, X. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.2124-22.2023 · Cited by 17
Effects of pharmacological agents, sleep deprivation, hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: Towards translational challenge models for drug discovery in Alzheimer’s disease
Babiloni, C., Infarinato, F., Aujard, F., Bastlund, J. F., Bentivoglio, M., Bertini, G., Percio, C. D., Fabene, P. F., Forloni, G., Ezquerro, M. T. H., et al. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2012.07.023 · Cited by 21
APOE4 Promotes Tonic-Clonic Seizures, an Effect Modified by Familial Alzheimer’s Disease Mutations
Lamoureux, L., Marottoli, F. M., Tseng, K. Y., & Tai, L. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.656521 · Cited by 21
Molecular Factors Mediating Neural Cell Plasticity Changes in Dementia Brain Diseases
Kozubski, W. P., Ong, K. T., Waleszczyk, W. J., Zabel, M. K., & Dorszewska, J. (2021) · Neural Plasticity · doi:10.1155/2021/8834645 · Cited by 21
Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients’ data analysis
Corniello, C., Dono, F., Evangelista, G., Consoli, S., Angelis, S. D., Cipollone, S., Liviello, D., Polito, G., Melchiorre, S., Russo, M., et al. (2023) · Seizure · doi:10.1016/j.seizure.2023.05.017 · Cited by 21
Expression of Phenotypic Astrocyte Marker Is Increased in a Transgenic Mouse Model of Alzheimer’s Disease versus Age-Matched Controls: A Presymptomatic Stage Study
Doméné, A., Cavanagh, C., Page, G., Bodard, S., Klein, C., Delarasse, C., Chalon, S., & Krantic, S. M. (2016) · International Journal of Alzheimer s Disease · doi:10.1155/2016/5696241 · Cited by 21
Quantitative EEG during normal aging: association with the Alzheimer's disease genetic risk variant in PICALM gene
Пономарева, Н. В., Андреева, Т. В., Protasova, M., Shagam, L. I., Malina, D. D., Goltsov, A. Y., Fokin, V. F., Illarioshkin, S. N., & Rogaev, E. I. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.010 · Cited by 21
Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative Disorders
Brzdąk, P., Nowak, D., Wiera, G., & Mozrzymas, J. W. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00178 · Cited by 21
Cholinergic Hypofunction in Presbycusis-Related Tinnitus With Cognitive Function Impairment: Emerging Hypotheses
Ruan, Q., Yu, Z., Zhang, W., Ruan, J., Liu, C., & Zhang, R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00098 · Cited by 21

Authors: Palop, J. J.
Affiliations: University of California, San Francisco (US)
Corresponding author: Palop, Jorge J.
ORCID: Palop, Jorge J.
Venue: Archives of Neurology
Publisher: American Medical Association (AMA)
Published: 2009-04-01
Volume: 66
Issue: 4
Pages: 435
ISSN: 0003-9942 (ISSN-L)
DOI: 10.1001/archneurol.2009.15
PMC: PMC2812914
OpenAlex: W2098676436
Cited by: 684
References: 47
Citations by year: 2026: 16 · 2025: 31 · 2024: 47 · 2023: 50 · 2022: 38 · 2021: 46 · 2020: 34 · 2019: 47 · 2018: 33 · 2017: 40 · 2016: 47 · 2015: 42 · 2014: 43 · 2013: 41 · 2012: 39
FWCI: 28.49
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Archives of Neurology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (AG023501, P50AG023501)
National Institute of Neurological Disorders and Stroke (R01NS041787, NS041787)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
Keywords: Alzheimer's disease, epilepsy, cognitive impairment, amyloid-beta, epileptiform activity, presenilin mutations, amyloid precursor protein, APOE ε4, early-onset Alzheimer's disease, transgenic mouse model, antiepileptic drugs
MeSH terms: Alzheimer Disease, Amnesia, Animals, Brain, Cognition Disorders, Disease Models, Animal, Electroencephalography, Epilepsy, Genetic Carrier Screening, Hippocampus, Humans, Mice, Transgenic, Nerve Net, Neural Inhibition, Synaptic Transmission, Picrotoxin, Amyloid beta-Peptides, tau Proteins, GABA Antagonists, Dentate Gyrus, Mice, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Epilepsy and Cognitive Impairments in Alzheimer Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks